05 Aug 22

Cambridge, UK, August 5th, 2022: We are excited to launch the o2h Kickstarter competition exclusively for early stage biotech to boost their drug discovery research. The programme aims to extend o2h discovery’s small molecule and medicinal chemistry research expertise to seed early stage biotech companies who have innovative ideas in drug science and are planning to push it forward to the next milestones. 

We understand that drug discovery research is a complex phenomenon. The first phase itself requires synthesis and screening of large numbers of new molecules to identify a “hit”. This initial phase we believe could be extremely time consuming as well as costly. The o2h kickstarter competition has been developed to provide a boost to small molecule focused biotech companies who need to supercharge their chemistry efforts to meet their next funding milestone.

o2h Discovery believes in working collaboratively and would like to play our part by supporting promising drug discovery research. Although this is a time-limited competition, if supportive to the global biotech ecosystem we will run this again.

The applications will be evaluated by the kickstarter committee including Sunil Shah, Co-founder of o2h group, Andy Morely, CSO of o2h discovery amongst others. The programme offers a dedicated team of six FTE chemists for each project, access to a large inventory of chemicals and reagents for synthesis in order to support small molecules research at reasonable costs. For more information and to apply, visit – https://o2h.com/the-o2h-kickstarter-competition/

Sunil Shah, Co-founder of o2h discovery, said:

“We have launched the kickstarter competition to help seed the next generation of biotech companies.  There are other parts of the biotech ecosystem such as funding, space and biology that we can add to this in the future but we thought given that chemistry is the life-blood of our company we would start with this first.  We are excited to review and see the companies that apply in this first wave.”


Editor Notes:

About o2h discovery:

Founded in 2005, o2h discovery is a Contract Research Organization which has an integrated drug discovery platform operating from its state-of-the-art research center in India and The Mill SciTech Park, Cambridge, UK. We have the in-house capability to execute hit-lead-optimization programs leading into patent and IND filing from our state-of-the-art biotechnology incubator with expertise in discovery chemistry, biology, pharmacology, and the ongoing project management of pre-clinical development. 

o2h discovery has developed and launched its proprietary application Chemistry in the Cloud™ (CITC), the world’s first app to revolutionize the project management of external drug discovery programs. The app enables the communication between various scientific stakeholders essential to successful project advancement – leading to faster decision making. 

The DNA of o2h discovery is centered around the nurturing of its people, values, and culture. It reflects in the way we work with each other, as well as our collaborators and partners. 

For more information about o2h group, please visit www.o2h.com and to know more about our chemistry services, please see – https://o2h.com/discovery/chemistry/